A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia | MicrobiomeTrials
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2025-09-26Est. Completion: 2027-11-30
Enrollment target: 28 participants
Locations
Zhengzhou Yihe Hospital, Zhengzhou, Henan, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China